---
figid: PMC6325856__12933_2019_806_Fig10_HTML
figlink: /pmc/articles/PMC6325856/figure/Fig10/
number: F10
caption: Schematic illustration of the proposed cardioprotective mechanism of mAb
  A treatment in hearts following a myocardial infarction. Glucagon receptor antagonism
  increases the insulin signalling pathway and the BCAA catabolic pathway, while inhibiting
  the mTOR pathway. IRS-1 insulin receptor substrate-1, Akt protein kinase B, GSK-3β
  glycogen synthase kinase-3 beta, mTOR mammalian target of rapamycin, P70S6K ribosomal
  protein S6 kinase, AS160 Akt substrate 160, GLUT4 glucose transporter 4, PDH pyruvate
  dehydrogenase, TAK1 transforming growth factor beta-activated kinase 1, p38 MAPK
  p38 mitogen-activated protein kinase, KLF15 Krüppel-like factor 15, BCATm mitochondrial
  branched chain aminotransferase, BCAA branched chain amino acids, TCA tricarboxylic
  acid, MPC mitochondrial pyruvate carrier. Red arrows indicate the cellular changes
  following mAb A treatment in post-MI heart
pmcid: PMC6325856
papertitle: Targeting the glucagon receptor improves cardiac function and enhances
  insulin sensitivity following a myocardial infarction.
reftext: Qutuba G. Karwi, et al. Cardiovasc Diabetol. 2019;18:1.
pmc_ranked_result_index: '101949'
pathway_score: 0.9681165
filename: 12933_2019_806_Fig10_HTML.jpg
figtitle: The proposed cardioprotective mechanism of mAb A treatment in hearts following
  a myocardial infarction
year: '2019'
organisms: Homo sapiens
ndex: 01b6cb7b-decd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6325856__12933_2019_806_Fig10_HTML.html
  '@type': Dataset
  description: Schematic illustration of the proposed cardioprotective mechanism of
    mAb A treatment in hearts following a myocardial infarction. Glucagon receptor
    antagonism increases the insulin signalling pathway and the BCAA catabolic pathway,
    while inhibiting the mTOR pathway. IRS-1 insulin receptor substrate-1, Akt protein
    kinase B, GSK-3β glycogen synthase kinase-3 beta, mTOR mammalian target of rapamycin,
    P70S6K ribosomal protein S6 kinase, AS160 Akt substrate 160, GLUT4 glucose transporter
    4, PDH pyruvate dehydrogenase, TAK1 transforming growth factor beta-activated
    kinase 1, p38 MAPK p38 mitogen-activated protein kinase, KLF15 Krüppel-like factor
    15, BCATm mitochondrial branched chain aminotransferase, BCAA branched chain amino
    acids, TCA tricarboxylic acid, MPC mitochondrial pyruvate carrier. Red arrows
    indicate the cellular changes following mAb A treatment in post-MI heart
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A4
  - GSK3B
  - ARID4B
  - MAPK13
  - MAPK14
  - TBC1D4
  - PDHA1
  - PDHB
  - AKT1
  - KLF15
  - MTOR
  - MAPK11
  - PDHX
  - AKT2
  - AKT3
  - MAPK12
  - PDHA2
  - DLAT
  - NR2C2
  - RPS6KB2
  - RPS6KB1
  - DLD
  - Glucose
  - Ir
  - Pyruvate
  - TCA
  - Pyruvate Acetyl
  - Acetyl CoA
  - Hypertrophy
  - Glucose oxidation
  - Glucose I Glucose
genes:
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: BCAA
  symbol: BCAA
  source: hgnc_alias_symbol
  hgnc_symbol: ARID4B
  entrez: '51742'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: AS160
  symbol: AS160
  source: hgnc_alias_symbol
  hgnc_symbol: TBC1D4
  entrez: '9882'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: KLF15
  symbol: KLF15
  source: hgnc_symbol
  hgnc_symbol: KLF15
  entrez: '28999'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Ir
  source: MESH
  identifier: D007495
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: TCA
  source: MESH
  identifier: C000589078
- word: Pyruvate Acetyl
  source: MESH
  identifier: D011773
- word: Acetyl CoA
  source: MESH
  identifier: D000105
diseases:
- word: Hypertrophy
  source: MESH
  identifier: D006984
- word: Glucose oxidation
  source: MESH
  identifier: D004194
- word: Glucose I Glucose
  source: MESH
  identifier: D018149
figid_alias: PMC6325856__F10
redirect_from: /figures/PMC6325856__F10
figtype: Figure
---
